Literature DB >> 1520250

Exogenous fructose-1,6-bisphosphate is a metabolizable substrate for the isolated normoxic rat heart.

B Tavazzi1, J W Starnes, G Lazzarino, D Di Pierro, E M Nuutinen, B Giardina.   

Abstract

Isolated rat hearts were perfused by the recirculating Langendorff mode under normoxic conditions for 60 min. The Krebs-Ringer buffer was supplemented with 10 mM glucose + 12 IU/l insulin and either [U-14C]-fructose-1,6-bisphosphate (together with 5 mM cold fructose-1,6-bisphosphate) or [U-14C]-fructose (together with 5 mM cold fructose). At the end of perfusion, gaseous 14CO2, 14CO2 trapped in the perfusates, 14C-lactate output and tissue 14C-lactate were assayed in both groups of hearts. Analysis of high-energy compounds, glycogen, lactate, and pyruvate was also performed on the neutralized perchloric acid extracts of the freeze-clamped hearts. Data obtained from the 14C catabolites, originating from the metabolism of the radiolabeled substrates, indicated that the isolated normoxic rat heart metabolizes an 8.5 times higher amount of fructose-1,6-bisphosphate (7.07 mumoles/min/g d.w.) than of fructose (0.83 mumoles/min/g d.w.). CrP, CrP/Cr, glycogen, and total lactate in both tissue and perfusate were significantly higher in fructose-1,6-bisphosphate-perfused hearts. The overall indication is that fructose-1,6-bisphosphate can be taken up in its intact form by myocytes and successively metabolized to support their energy demand, and that its effects on myocardial performance and metabolism should be attributed to the molecule itself rather than to its eventual degradation products.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1520250     DOI: 10.1007/bf00804337

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  20 in total

1.  Preserving effect of fructose-1,6-bisphosphate on high-energy phosphate compounds during anoxia and reperfusion in isolated langendorff-perfused rat hearts.

Authors:  G Lazzarino; M E Nuutinen; B Tavazzi; L Cerroni; D Di Pierro; B Giardina
Journal:  J Mol Cell Cardiol       Date:  1991-01       Impact factor: 5.000

2.  Fructose-1,6-bisphosphate protects astrocytes from hypoxic damage.

Authors:  G A Gregory; A C Yu; P H Chan
Journal:  J Cereb Blood Flow Metab       Date:  1989-02       Impact factor: 6.200

3.  Oxygen radical injury and loss of high-energy compounds in anoxic and reperfused rat heart: prevention by exogenous fructose-1,6-bisphosphate.

Authors:  B Tavazzi; L Cerroni; D Di Pierro; G Lazzarino; M Nuutinen; J W Starnes; B Giardina
Journal:  Free Radic Res Commun       Date:  1990

4.  Protective role of fructose 1,6-bisphosphate during CCl4 hepatotoxicity in rats.

Authors:  S B Rao; H M Mehendale
Journal:  Biochem J       Date:  1989-09-15       Impact factor: 3.857

5.  Effect of exogenous fructose-1,6-bisphosphate on glycolysis in the isolated perfused rat heart.

Authors:  E M Nuutinen; G Lazzarino; B Giardina; I E Hassinen
Journal:  Am Heart J       Date:  1991-08       Impact factor: 4.749

6.  Reperfusion with ATP-MgCl2 following prolonged ischemia improves myocardial performance.

Authors:  G S Kopf; I Chaudry; S Condos; A E Baue
Journal:  J Surg Res       Date:  1987-08       Impact factor: 2.192

7.  Improved exercise tolerance by i.v. fructose-1,6-diphosphate in chronic, stable angina pectoris.

Authors:  N Marchionni; G Moschi; M Di Bari; L Ferrucci; M Paoletti; B Salani; F Fattirolli
Journal:  J Clin Pharmacol       Date:  1988-09       Impact factor: 3.126

8.  Fatty acid metabolism in hearts containing elevated levels of CoA.

Authors:  G D Lopaschuk; C A Hansen; J R Neely
Journal:  Am J Physiol       Date:  1986-03

9.  Improved left ventricular function after short-term treatment with fructose-1,6-diphosphate: echocardiographic study in chronic ischemic heart disease and idiopathic dilated cardiomyopathy.

Authors:  A M Grandi; C Muggia; F Barzizza; A Venco; G Finardi
Journal:  Clin Ther       Date:  1988       Impact factor: 3.393

10.  Mechanism of the effect of exogenous fructose 1,6-bisphosphate on myocardial energy metabolism.

Authors:  I E Hassinen; E M Nuutinen; K Ito; S Nioka; G Lazzarino; B Giardina; B Chance
Journal:  Circulation       Date:  1991-02       Impact factor: 29.690

View more
  7 in total

1.  Characterization of the high-affinity uptake of fructose-1,6-bisphosphate by cardiac myocytes.

Authors:  Thomas J Wheeler; Sufan Chien
Journal:  Mol Cell Biochem       Date:  2012-03-18       Impact factor: 3.396

Review 2.  Current state of hypothermic machine perfusion preservation of organs: The clinical perspective.

Authors:  Michael J Taylor; Simona C Baicu
Journal:  Cryobiology       Date:  2009-10-24       Impact factor: 2.487

3.  Fructose-1,6-diphosphate attenuates prostaglandin E2 production and cyclo-oxygenase-2 expression in UVB-irradiated HaCaT keratinocytes.

Authors:  Soo Mi Ahn; Hyoung-Young Yoon; Byung Gon Lee; Kyoung Chan Park; Jin Ho Chung; Chang-Hyun Moon; Soo Hwan Lee
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

4.  Permeability of fructose-1,6-bisphosphate in liposomes and cardiac myocytes.

Authors:  Thomas J Wheeler; John M McCurdy; Aaron denDekker; Sufan Chien
Journal:  Mol Cell Biochem       Date:  2004-04       Impact factor: 3.396

5.  Fructose-1,6-Bisphosphate inhibits excess activation of Kupffer cell function induced by endotoxin.

Authors:  Takuya Tamaki; Takehiro Nakai; Hiroki Yamaue
Journal:  Dig Dis Sci       Date:  2002-10       Impact factor: 3.199

6.  Fructose modulates cardiomyocyte excitation-contraction coupling and Ca²⁺ handling in vitro.

Authors:  Kimberley M Mellor; James R Bell; Igor R Wendt; Amy J Davidoff; Rebecca H Ritchie; Lea M D Delbridge
Journal:  PLoS One       Date:  2011-09-29       Impact factor: 3.240

7.  Fructose-1,6-Bisphosphate Protects Hippocampal Rat Slices from NMDA Excitotoxicity.

Authors:  Kamal M Yakoub; Giacomo Lazzarino; Angela M Amorini; Giuseppe Caruso; Concetta Scazzone; Marcello Ciaccio; Barbara Tavazzi; Giuseppe Lazzarino; Antonio Belli; Valentina Di Pietro
Journal:  Int J Mol Sci       Date:  2019-05-07       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.